Inventor · disambiguated record
Willow Diluzio
Also filed as: DILUZIO WILLOW · DILUZIO WILLOW R · DILUZIO WILLOW RUTH
7 granted patents·12 pending applications·190 citations·filing 2002–2025
88Inventor score
Files withMILLENNIUM PHARM INC11TAKEDA PHARMACEUTICALS CO3DILUZIO WILLOW2SAREPTA THERAPEUTICS INC1TAKEDA GMBH1
Top patents by PatentIndex Score
19 records- 0195US11560434B2Formulation for anti-α4β7 antibodyMILLENNIUM PHARM INC·Filed 2020·Granted Jan 24, 2023·7 cites·33 claims
- 0295USD866757SAutoinjectorMILLENNIUM PHARM INC·Filed 2016·Granted Nov 12, 2019·87 cites·1 claims
- 0394US9764033B2Formulation for anti-α4β7 antibodyDILUZIO WILLOW·Filed 2012·Granted Sep 19, 2017·32 cites·33 claims
- 0493USD1038380SAutoinjectorMILLENNIUM PHARM INC·Filed 2023·Granted Aug 6, 2024·16 cites·1 claims
- 0591US2025041424A1Methods for treatment using anti-alpha4beta7 antibodyTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0690US10040855B2Formulation for anti-α4β7 antibodyDILUZIO WILLOW·Filed 2012·Granted Aug 7, 2018·19 cites·29 claims
- 0790US2025000981A1Methods for treatment using anti-alpha4beta7 antibodyTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0889USD1010817SAutoinjectorMILLENNIUM PHARM INC·Filed 2019·Granted Jan 9, 2024·27 cites·1 claims
- 0987US2025034263A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2024·Application pending·0 cites
- 1086US2025295786A1Methods for treatment using anti-alpha4beta7 antibodyTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 1182US11173208B2Liquid formulation comprising GM-CSF neutralizing compoundTAKEDA GMBH·Filed 2015·Granted Nov 16, 2021·2 cites·11 claims
- 1281US2022370617A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2022·Application pending·0 cites
- 1380US2023312727A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2022·Application pending·0 cites
- 1471US2019231878A1Formulation for anti-alpha4beta7 antibody and methods of treatmentMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 1567US2019076532A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2017·Application pending·0 cites
- 1663US2018346578A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 1763US2018327497A1Formulation for anti-alpha4beta7 antibodyMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 1861US2024327831A1Compositions comprising exon skipping oligonucleotide conjugates for treating muscular dystrophySAREPTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1942US2003049158A1Stablization and terminal sterilization of phospholipid formulationsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Willow Diluzio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →